Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spiess

Showing results (331-340 of 566) with videos related to

Pageof 57
Sort By:
Cancer|October 24, 2007
Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?Philippe E Spiess, Nizar M Tannir, Shi-Ming Tu, et al.
The Journal of Urology|August 4, 2015
Preoperative Patient Reported Mental Health is Associated with High Grade Complications after Radical CystectomyPranav Sharma, Carl H Henriksen, Kamran Zargar-Shoshtari, et al.
Cancer|January 22, 2009
Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissectionRobert S Svatek, Philippe E Spiess, Debasish Sundi, et al.
Cancer Treatment Reviews|October 20, 2022
HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverageGaia Giannone, Anna R Giuliano, Marco Bandini, et al.
The Canadian Journal of Urology|February 20, 2016
Is percent seminoma associated with intraoperative morbidity during post-chemotherapy RPLND?Christopher M Russell, Pranav Sharma, Gautum Agarwal, et al.
European Urology Focus|February 14, 2018
Surgical and Oncological Outcomes in Patients After Vascularised Flap Reconstruction for Locoregionally Advanced Penile CancerSarah R Ottenhof, Andrew Leone, Rosa S Djajadiningrat, et al.
Urologic Oncology|January 9, 2007
Review of the M.D. Anderson experience in the treatment of bladder sarcomaPhilippe E Spiess, Wassim Kassouf, Jordan R Steinberg, et al.
European Urology Focus|August 2, 2025
Urinary Tumor DNA-based Liquid Biopsy in Bladder Cancer Management: A Systematic ReviewJoanne Lee, Fei Chen, Antonio Lopez-Beltran, et al.
Clinical Genitourinary Cancer|November 7, 2022
Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources UniformlyAndrea Necchi, Monika Joshi, Rick Bangs, et al.
Anticancer Research|March 2, 2005
Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancerB Werle, M Kotzsch, T T Lah, et al.
Pageof 57

Showing results (331-340 of 566) with videos related to

Sort By:
Pageof 57
Cancer|October 24, 2007
Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?Philippe E Spiess, Nizar M Tannir, Shi-Ming Tu, et al.
The Journal of Urology|August 4, 2015
Preoperative Patient Reported Mental Health is Associated with High Grade Complications after Radical CystectomyPranav Sharma, Carl H Henriksen, Kamran Zargar-Shoshtari, et al.
Cancer|January 22, 2009
Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissectionRobert S Svatek, Philippe E Spiess, Debasish Sundi, et al.
Cancer Treatment Reviews|October 20, 2022
HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverageGaia Giannone, Anna R Giuliano, Marco Bandini, et al.
The Canadian Journal of Urology|February 20, 2016
Is percent seminoma associated with intraoperative morbidity during post-chemotherapy RPLND?Christopher M Russell, Pranav Sharma, Gautum Agarwal, et al.
European Urology Focus|February 14, 2018
Surgical and Oncological Outcomes in Patients After Vascularised Flap Reconstruction for Locoregionally Advanced Penile CancerSarah R Ottenhof, Andrew Leone, Rosa S Djajadiningrat, et al.
Urologic Oncology|January 9, 2007
Review of the M.D. Anderson experience in the treatment of bladder sarcomaPhilippe E Spiess, Wassim Kassouf, Jordan R Steinberg, et al.
European Urology Focus|August 2, 2025
Urinary Tumor DNA-based Liquid Biopsy in Bladder Cancer Management: A Systematic ReviewJoanne Lee, Fei Chen, Antonio Lopez-Beltran, et al.
Clinical Genitourinary Cancer|November 7, 2022
Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources UniformlyAndrea Necchi, Monika Joshi, Rick Bangs, et al.
Anticancer Research|March 2, 2005
Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancerB Werle, M Kotzsch, T T Lah, et al.
Pageof 57